NPCA Annual Report 2019

Published by:
Healthcare Quality Improvement Partnership
Last updated:
17 April 2023
Topic:
Not added
Licence:
Creative Commons Attribution

Summary

In the 2019 Annual Report, we present the results for patients diagnosed between 1st April 2017 and 31st March 2018 in England and Wales including: 1. The participation of NHS providers and the completeness and quality of the data submitted to the National Cancer Registration and Analysis Service (NCRAS), Public Health England and the Wales Cancer Network, Public Health Wales. 2. Patient demographic information, key aspects of the diagnostic and staging process they underwent and the treatments they received. 3. The variation in disease presentation and treatment allocation across NHS providers in England and Wales. For the first time, we report on the use of docetaxel, brachytherapy boost (high-dose rate and low-dose rate) and radiotherapy hypofractionation in England. In addition, we present: 4. Treatment outcomes (up to two years post-treatment) for men in England and Wales undergoing radical prostatectomy (RP) or radical external beam radiotherapy (EBRT) in 2016.

More from this publisher

All datasets from Healthcare Quality Improvement Partnership

Related datasets

Search

Data links

Link to the data Format File added Data preview
NPCA Annual Report 2019 PDF 06 March 2020 Not available
NPCA Annual Report 2019 Open data field list XLSX 06 March 2020 Not available
NPCA Annual Report 2019 open data ODS 06 March 2020 Not available

Contact

Enquiries

Healthcare Quality Improvement Partnership

Freedom of Information (FOI) requests

Healthcare Quality Improvement Partnership Freedom of information requests for this dataset

Edit this dataset

You must have an account for this publisher on data.gov.uk to make any changes to a dataset.

Sign in